All stock reports

GREAVESCOT evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-09T14:01:18.786602+00:00

Metrics

latest_annual_period
2026-03-31
revenue
34366200000.0
net_income
1071400000.0
operating_cash_flow
640200000.0
free_cash_flow
274800000.0
total_assets
28938000000.0
total_liabilities
13797800000.0
total_equity
14307200000.0
cash
5635300000.0
total_debt
3944200000.0
revenue_growth
0.1775537615986622
earnings_growth
0.8345890410958905
net_margin
0.031175981051149094
roe
0.07488537239991054
debt_to_equity
0.2756793782151644
cash_conversion
0.5975359342915811
free_cash_flow_margin
0.007996228852768126
trailing_pe
27.32
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
Not supplied
dividend_yield
Not supplied

Other positional research

No qualifying opportunity

No candidate at another positional horizon in the coherent source run.

  • No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
Decision ID
decision-a9cd09ad762012977e60d3f3c625c5d99b9fec5c85ec6c9ca242458e52d8ca2d
Policy
stock-decisions-v1
Evidence bundle hash
dee7e0f6bf95a1838a5e6e02d219171d1e61fe41b33c3ea8c071ffc9beef5ded
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 9e2cf85847fcdf1da4ef8ffdbe6622a33c421ee45b96104d48046ddbd1c25e39
  • daily-price: cd17b7e08409c86965319b7257285a35c9de53a9d3cf9d83584d6567613e9866
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: VERIFIED. The trailing 5-session price return was 1.68%. The trailing 20-session price return was 16.26%. The trailing 60-session price return was 0.90%. The trailing 250-session price return was 5.67%. Average cached traded value over twenty sessions was INR 545,623,722.

Risks

The closing price was -13.42% below its highest close in the available trailing year. The cached financial metric free cash flow margin is 0.007996228852768126. Financial data check: balance_sheet_equation: difference=833000000.00. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

The cached financial metric latest annual period is 2026-03-31. The cached financial metric revenue growth is 0.1775537615986622. The cached financial metric net margin is 0.031175981051149094. The cached financial metric roe is 0.07488537239991054. The cached financial metric debt to equity is 0.2756793782151644. The cached financial metric cash conversion is 0.5975359342915811.

Cached observations and evidence limits